At the Carle Neuroscience Insitute in Urbana, patient-tailored care is the focus of our multidisciplinary team, we create a treatement plan specifically for you. Patients will be assessed by our team of specialists in one consultation visit. Our experts in all types of brain and spinal cord tumors, including the most complex skull base tumors, meet to thoroughly discuss every case as group. We formulate a customized plan from diagnosis to treatment and follow-up. With each physician focused on a different aspect of our patient's health, we can quickly identify areas of need, and subsequently manage those needs in an effective way.
Our multidisciplinary team is made up of providers from several clinical specialites;
Treatment options can include one or more of the following:
Endoscopic transnasal resection of skull base tumors
Real-time fluorescence image-guided tumor resection
Resection of brain tumor near speech cortex and motor areas (using planning with diffusion tensor imaging, functional MRI)
Awake craniotomy/brain mapping for resection of brain tumors
Delivery of local chemotherapy during resection of malignant brain tumors
Resection of complex brain tumors, including acoustic neuromas
High end technology in radiation treatments including stereotactic radiosurgery and intensity-modulated radiation therapy (IMRT)
Access to clinical trials
GammaTile® is an innovative treatment for patients with operable brain tumors. This bioabsorbable collagen tile uses MRI-safe titanium seeds to deliver targeted radiation therapy to a patient after tumor removal.
During the procedure, a neurosurgeon places the GammaTile® (s) at the site of the tumor immediately after the tumor has been removed. Radiation is delivered to the site of the tumor to help prevent recurrence, and patients return to daily life while receiving radiation therapy from the tile.
GammaTile® is designed to protect healthy tissue and minimize radiation side effects, including hair loss, while delivering radiation therapy. With this treatment, patients aren’t required to be at a medical facility to receive treatment and can focus on recovering from surgery at home.
Carle Health is the first and only healthcare system in central Illinois to offer GammaTile® as a treatment option for patients with a brain and skull base tumor. Led by Wael Mostafa, MD, PhD, program lead for brain tumor and skull base surgery at Carle Health, the GammaTile® treatment contributes to the ongoing advancements in tumor care and the field of neuroscience.
The removal of brain, spine and skull base tumors can be some of the most intricate, complex procedures performed by surgeons. Dr. Wael Mostafa, Neurosurgeon and head of the Carle Brain Tumor Program, explains more in this episode of WEIU PBS Being Well.
The American Brain Tumor Association (ABTA) is a trusted partner of the Carle Neuroscience Institute in Urbana. The ABTA was the first national advocacy organization committed to funding brain tumor research and providing information and education to patients, caregivers, and their loved ones.
For 50 years, the ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care.
Please Contact Us if you have any questions.
